Relevant findings suggest that the intrahepatic impairment of the thyroid hormone (TH) pathway due to thyroid hormone receptor beta (THRB) gene mutations may lead to fatty liver; TH resistance can thus take part in NAFLD development [29]. Here, THRB is linked to metabolic dysfunction-associated steatotic liver disease.